{
  "success": true,
  "pagesUsed": [
    4,
    13,
    14,
    17
  ],
  "modelUsed": "gemini-3-flash-preview",
  "narrative": {
    "narrativeContents": [
      {
        "id": "nc_1",
        "name": "SYNOPSIS",
        "text": "SYNOPSIS",
        "order": 0,
        "instanceType": "NarrativeContent",
        "sectionNumber": "N/A",
        "sectionTitle": "SYNOPSIS",
        "sectionType": {
          "id": "7db72f29-84d3-4f9c-995d-7f7c4bca095d",
          "code": "Synopsis",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Synopsis",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_2",
        "name": "INTRODUCTION AND STUDY RATIONALE",
        "text": "INTRODUCTION AND STUDY RATIONALE",
        "order": 1,
        "instanceType": "NarrativeContent",
        "sectionNumber": "1",
        "sectionTitle": "INTRODUCTION AND STUDY RATIONALE",
        "sectionType": {
          "id": "a87a7db4-c9f6-442b-9165-5f5529b41278",
          "code": "Introduction",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Introduction",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_2_1",
          "nci_2_2",
          "nci_2_3",
          "nci_2_4",
          "nci_2_5",
          "nci_2_6",
          "nci_2_7",
          "nci_2_8",
          "nci_2_9",
          "nci_2_10",
          "nci_2_11",
          "nci_2_12"
        ]
      },
      {
        "id": "nc_3",
        "name": "ETHICAL CONSIDERATIONS",
        "text": "ETHICAL CONSIDERATIONS",
        "order": 2,
        "instanceType": "NarrativeContent",
        "sectionNumber": "2",
        "sectionTitle": "ETHICAL CONSIDERATIONS",
        "sectionType": {
          "id": "e13164c9-957e-4099-a256-67a9d1df6c70",
          "code": "Ethics",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Ethics",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_3_1",
          "nci_3_2",
          "nci_3_3"
        ]
      },
      {
        "id": "nc_4",
        "name": "INVESTIGATIONAL PLAN",
        "text": "INVESTIGATIONAL PLAN",
        "order": 3,
        "instanceType": "NarrativeContent",
        "sectionNumber": "3",
        "sectionTitle": "INVESTIGATIONAL PLAN",
        "sectionType": {
          "id": "31d97b81-343c-40ec-8117-b405e7846ea0",
          "code": "Study Design",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Study Design",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_4_1",
          "nci_4_2",
          "nci_4_3",
          "nci_4_4",
          "nci_4_5",
          "nci_4_6",
          "nci_4_7",
          "nci_4_8",
          "nci_4_9",
          "nci_4_10",
          "nci_4_11",
          "nci_4_12",
          "nci_4_13",
          "nci_4_14"
        ]
      },
      {
        "id": "nc_5",
        "name": "STUDY DRUG",
        "text": "STUDY DRUG",
        "order": 4,
        "instanceType": "NarrativeContent",
        "sectionNumber": "4",
        "sectionTitle": "STUDY DRUG",
        "sectionType": {
          "id": "e841351b-04ad-420d-8b1b-c6f85a19a3e0",
          "code": "Treatment",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Treatment",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_5_1",
          "nci_5_2",
          "nci_5_3",
          "nci_5_4",
          "nci_5_5"
        ]
      },
      {
        "id": "nc_6",
        "name": "STUDY MANAGEMENT",
        "text": "STUDY MANAGEMENT",
        "order": 5,
        "instanceType": "NarrativeContent",
        "sectionNumber": "9",
        "sectionTitle": "STUDY MANAGEMENT",
        "sectionType": {
          "id": "5f89bb4d-5efb-430e-bff9-e513bb673bdb",
          "code": "Other",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Other",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_6_1",
          "nci_6_2",
          "nci_6_3",
          "nci_6_4",
          "nci_6_5",
          "nci_6_6",
          "nci_6_7",
          "nci_6_8",
          "nci_6_9"
        ]
      },
      {
        "id": "nc_7",
        "name": "GLOSSARY OF TERMS",
        "text": "GLOSSARY OF TERMS",
        "order": 6,
        "instanceType": "NarrativeContent",
        "sectionNumber": "10",
        "sectionTitle": "GLOSSARY OF TERMS",
        "sectionType": {
          "id": "887d0001-92e8-4619-9dbb-30544dd48a34",
          "code": "Other",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Other",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_8",
        "name": "LIST OF ABBREVIATIONS",
        "text": "LIST OF ABBREVIATIONS",
        "order": 7,
        "instanceType": "NarrativeContent",
        "sectionNumber": "11",
        "sectionTitle": "LIST OF ABBREVIATIONS",
        "sectionType": {
          "id": "0f8ea914-2e10-437e-a672-0e4059a1ec9c",
          "code": "Other",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Other",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_9",
        "name": "REFERENCES",
        "text": "REFERENCES",
        "order": 8,
        "instanceType": "NarrativeContent",
        "sectionNumber": "12",
        "sectionTitle": "REFERENCES",
        "sectionType": {
          "id": "d44929c9-6a9b-4fe0-b76a-81aaf3a99e84",
          "code": "References",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "References",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_10",
        "name": "NEW YORK HEART ASSOCIATION FUNCTIONAL CLASS",
        "text": "NEW YORK HEART ASSOCIATION FUNCTIONAL CLASS",
        "order": 9,
        "instanceType": "NarrativeContent",
        "sectionNumber": "APPENDIX 1",
        "sectionTitle": "NEW YORK HEART ASSOCIATION FUNCTIONAL CLASS",
        "sectionType": {
          "id": "2594810c-677b-4448-99ad-c20babf33d70",
          "code": "Appendix",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Appendix",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_11",
        "name": "CENTRAL LABORATORY ASSESSMENTS",
        "text": "CENTRAL LABORATORY ASSESSMENTS",
        "order": 10,
        "instanceType": "NarrativeContent",
        "sectionNumber": "APPENDIX 2",
        "sectionTitle": "CENTRAL LABORATORY ASSESSMENTS",
        "sectionType": {
          "id": "bc23d3c0-fdb9-4b3b-8a68-32b0b26c9d0f",
          "code": "Appendix",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Appendix",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_12",
        "name": "SUSTAINED ELEVATED LIVER SAFETY ABNORMALITIES FLOW CHART",
        "text": "SUSTAINED ELEVATED LIVER SAFETY ABNORMALITIES FLOW CHART",
        "order": 11,
        "instanceType": "NarrativeContent",
        "sectionNumber": "APPENDIX 3",
        "sectionTitle": "SUSTAINED ELEVATED LIVER SAFETY ABNORMALITIES FLOW CHART",
        "sectionType": {
          "id": "409d1a96-25cd-4f17-ad74-3ac8e183d724",
          "code": "Appendix",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Appendix",
          "instanceType": "Code"
        }
      }
    ],
    "narrativeContentItems": [
      {
        "id": "nci_2_1",
        "name": "Study Rationale",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.1",
        "sectionTitle": "Study Rationale"
      },
      {
        "id": "nci_2_2",
        "name": "Unmet Medical Need in Type 1 Diabetes Mellitus",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.1.1",
        "sectionTitle": "Unmet Medical Need in Type 1 Diabetes Mellitus"
      },
      {
        "id": "nci_2_3",
        "name": "Introduction of Dapagliflozin and Study Rationale",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.1.2",
        "sectionTitle": "Introduction of Dapagliflozin and Study Rationale"
      },
      {
        "id": "nci_2_4",
        "name": "Research Hypothesis",
        "text": "",
        "order": 3,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.2",
        "sectionTitle": "Research Hypothesis"
      },
      {
        "id": "nci_2_5",
        "name": "Objectives",
        "text": "",
        "order": 4,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.3",
        "sectionTitle": "Objectives"
      },
      {
        "id": "nci_2_6",
        "name": "Primary Objectives",
        "text": "",
        "order": 5,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.3.1",
        "sectionTitle": "Primary Objectives"
      },
      {
        "id": "nci_2_7",
        "name": "Secondary Objectives",
        "text": "",
        "order": 6,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.3.2",
        "sectionTitle": "Secondary Objectives"
      },
      {
        "id": "nci_2_8",
        "name": "Efficacy",
        "text": "",
        "order": 7,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.3.2.1",
        "sectionTitle": "Efficacy"
      },
      {
        "id": "nci_2_9",
        "name": "Safety",
        "text": "",
        "order": 8,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.3.2.2",
        "sectionTitle": "Safety"
      },
      {
        "id": "nci_2_10",
        "name": "Other/Exploratory Objectives",
        "text": "",
        "order": 9,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.3.3",
        "sectionTitle": "Other/Exploratory Objectives"
      },
      {
        "id": "nci_2_11",
        "name": "Product Development Background",
        "text": "",
        "order": 10,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.4",
        "sectionTitle": "Product Development Background"
      },
      {
        "id": "nci_2_12",
        "name": "Overall Risk/Benefit Assessment",
        "text": "",
        "order": 11,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.5",
        "sectionTitle": "Overall Risk/Benefit Assessment"
      },
      {
        "id": "nci_3_1",
        "name": "Good Clinical Practice",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "2.1",
        "sectionTitle": "Good Clinical Practice"
      },
      {
        "id": "nci_3_2",
        "name": "Institutional Review Board (IRB)/Independent Ethics Committee (IEC)",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "2.2",
        "sectionTitle": "Institutional Review Board (IRB)/Independent Ethics Committee (IEC)"
      },
      {
        "id": "nci_3_3",
        "name": "Informed Consent",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "2.3",
        "sectionTitle": "Informed Consent"
      },
      {
        "id": "nci_4_1",
        "name": "Study Design and Duration",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.1",
        "sectionTitle": "Study Design and Duration"
      },
      {
        "id": "nci_4_2",
        "name": "Post Study Access to Therapy",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.2",
        "sectionTitle": "Post Study Access to Therapy"
      },
      {
        "id": "nci_4_3",
        "name": "Study Population",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.3",
        "sectionTitle": "Study Population"
      },
      {
        "id": "nci_4_4",
        "name": "Inclusion Criteria",
        "text": "",
        "order": 3,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.3.1",
        "sectionTitle": "Inclusion Criteria"
      },
      {
        "id": "nci_4_5",
        "name": "Exclusion Criteria",
        "text": "",
        "order": 4,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.3.2",
        "sectionTitle": "Exclusion Criteria"
      },
      {
        "id": "nci_4_6",
        "name": "Women of Childbearing Potential",
        "text": "",
        "order": 5,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.3.3",
        "sectionTitle": "Women of Childbearing Potential"
      },
      {
        "id": "nci_4_7",
        "name": "Concomitant Treatments",
        "text": "",
        "order": 6,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.4",
        "sectionTitle": "Concomitant Treatments"
      },
      {
        "id": "nci_4_8",
        "name": "Prohibited and/or Restricted Treatments",
        "text": "",
        "order": 7,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.4.1",
        "sectionTitle": "Prohibited and/or Restricted Treatments"
      },
      {
        "id": "nci_4_9",
        "name": "Other Restrictions and Precautions",
        "text": "",
        "order": 8,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.4.2",
        "sectionTitle": "Other Restrictions and Precautions"
      },
      {
        "id": "nci_4_10",
        "name": "Discontinuation of Subjects from Treatment",
        "text": "",
        "order": 9,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.5",
        "sectionTitle": "Discontinuation of Subjects from Treatment"
      },
      {
        "id": "nci_4_11",
        "name": "Discontinuation Guidelines due to Protocol-Defined Hypoglycemia Episode or Recurrent Hypoglycemia Episodes",
        "text": "",
        "order": 10,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.5.1",
        "sectionTitle": "Discontinuation Guidelines due to Protocol-Defined Hypoglycemia Episode or Recurrent Hypoglycemia Episodes"
      },
      {
        "id": "nci_4_12",
        "name": "Post Study Drug Study Follow up",
        "text": "",
        "order": 11,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.6",
        "sectionTitle": "Post Study Drug Study Follow up"
      },
      {
        "id": "nci_4_13",
        "name": "Withdrawal of Consent",
        "text": "",
        "order": 12,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.6.1",
        "sectionTitle": "Withdrawal of Consent"
      },
      {
        "id": "nci_4_14",
        "name": "Lost to Follow-Up",
        "text": "",
        "order": 13,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.6.2",
        "sectionTitle": "Lost to Follow-Up"
      },
      {
        "id": "nci_5_1",
        "name": "Investigational Product",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "4.1",
        "sectionTitle": "Investigational Product"
      },
      {
        "id": "nci_5_2",
        "name": "Non-investigational Product",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "4.2",
        "sectionTitle": "Non-investigational Product"
      },
      {
        "id": "nci_5_3",
        "name": "Storage and Dispensing",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "4.3",
        "sectionTitle": "Storage and Dispensing"
      },
      {
        "id": "nci_5_4",
        "name": "Method of Assigning Subject Identification",
        "text": "",
        "order": 3,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "4.4",
        "sectionTitle": "Method of Assigning Subject Identification"
      },
      {
        "id": "nci_5_5",
        "name": "Subjects entering the 24-week double-blinded short-term treatment period",
        "text": "",
        "order": 4,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "4.4.1",
        "sectionTitle": "Subjects entering the 24-week double-blinded short-term treatment period"
      },
      {
        "id": "nci_6_1",
        "name": "Compliance",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "9.1",
        "sectionTitle": "Compliance"
      },
      {
        "id": "nci_6_2",
        "name": "Compliance with the Protocol and Protocol Revisions",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "9.1.1",
        "sectionTitle": "Compliance with the Protocol and Protocol Revisions"
      },
      {
        "id": "nci_6_3",
        "name": "Monitoring",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "9.1.2",
        "sectionTitle": "Monitoring"
      },
      {
        "id": "nci_6_4",
        "name": "Investigational Site Training",
        "text": "",
        "order": 3,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "9.1.3",
        "sectionTitle": "Investigational Site Training"
      },
      {
        "id": "nci_6_5",
        "name": "Records",
        "text": "",
        "order": 4,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "9.2",
        "sectionTitle": "Records"
      },
      {
        "id": "nci_6_6",
        "name": "Records Retention",
        "text": "",
        "order": 5,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "9.2.1",
        "sectionTitle": "Records Retention"
      },
      {
        "id": "nci_6_7",
        "name": "Study Drug Records",
        "text": "",
        "order": 6,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "9.2.2",
        "sectionTitle": "Study Drug Records"
      },
      {
        "id": "nci_6_8",
        "name": "Case Report Forms",
        "text": "",
        "order": 7,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "9.2.3",
        "sectionTitle": "Case Report Forms"
      },
      {
        "id": "nci_6_9",
        "name": "Clinical Study Report and Publications",
        "text": "",
        "order": 8,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "9.3",
        "sectionTitle": "Clinical Study Report and Publications"
      }
    ],
    "abbreviations": [
      {
        "id": "abbr_1",
        "abbreviatedText": "HbA1c",
        "expandedText": "hemoglobin A1c",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_2",
        "abbreviatedText": "T1DM",
        "expandedText": "type 1 diabetes mellitus",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_3",
        "abbreviatedText": "CGM",
        "expandedText": "continuous glucose monitoring",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_4",
        "abbreviatedText": "MAGE",
        "expandedText": "mean amplitude of glucose excursion",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_5",
        "abbreviatedText": "MNAR",
        "expandedText": "missing-not-at-random",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_6",
        "abbreviatedText": "PK",
        "expandedText": "Pharmacokinetics",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_7",
        "abbreviatedText": "IRB",
        "expandedText": "Institutional Review Board",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_8",
        "abbreviatedText": "IEC",
        "expandedText": "Independent Ethics Committee",
        "instanceType": "Abbreviation"
      }
    ],
    "summary": {
      "sectionCount": 12,
      "itemCount": 43,
      "abbreviationCount": 8
    },
    "studyDefinitionDocument": {
      "id": "sdd_1",
      "name": "A Multicenter, Randomized, Double-Blind, Placebo-controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Dapagliflozin as an Add-on to Insulin Therapy in Subjects with Type 1 Diabetes Mellitus - Study Two",
      "documentType": "Protocol",
      "language": "en",
      "instanceType": "StudyDefinitionDocument",
      "version": "02",
      "versionDate": "18-May-2016",
      "contentIds": [
        "nc_1",
        "nc_2",
        "nc_3",
        "nc_4",
        "nc_5",
        "nc_6",
        "nc_7",
        "nc_8",
        "nc_9",
        "nc_10",
        "nc_11",
        "nc_12"
      ]
    }
  },
  "rawResponse": {
    "abbreviations": {
      "abbreviations": [
        {
          "abbreviation": "HbA1c",
          "expansion": "hemoglobin A1c"
        },
        {
          "abbreviation": "T1DM",
          "expansion": "type 1 diabetes mellitus"
        },
        {
          "abbreviation": "CGM",
          "expansion": "continuous glucose monitoring"
        },
        {
          "abbreviation": "MAGE",
          "expansion": "mean amplitude of glucose excursion"
        },
        {
          "abbreviation": "MNAR",
          "expansion": "missing-not-at-random"
        },
        {
          "abbreviation": "PK",
          "expansion": "Pharmacokinetics"
        },
        {
          "abbreviation": "IRB",
          "expansion": "Institutional Review Board"
        },
        {
          "abbreviation": "IEC",
          "expansion": "Independent Ethics Committee"
        }
      ]
    },
    "structure": {
      "document": {
        "title": "A Multicenter, Randomized, Double-Blind, Placebo-controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Dapagliflozin as an Add-on to Insulin Therapy in Subjects with Type 1 Diabetes Mellitus - Study Two",
        "version": "02",
        "versionDate": "18-May-2016"
      },
      "sections": [
        {
          "number": "N/A",
          "title": "SYNOPSIS",
          "type": "Synopsis"
        },
        {
          "number": "1",
          "title": "INTRODUCTION AND STUDY RATIONALE",
          "type": "Introduction",
          "subsections": [
            {
              "number": "1.1",
              "title": "Study Rationale"
            },
            {
              "number": "1.1.1",
              "title": "Unmet Medical Need in Type 1 Diabetes Mellitus"
            },
            {
              "number": "1.1.2",
              "title": "Introduction of Dapagliflozin and Study Rationale"
            },
            {
              "number": "1.2",
              "title": "Research Hypothesis"
            },
            {
              "number": "1.3",
              "title": "Objectives"
            },
            {
              "number": "1.3.1",
              "title": "Primary Objectives"
            },
            {
              "number": "1.3.2",
              "title": "Secondary Objectives"
            },
            {
              "number": "1.3.2.1",
              "title": "Efficacy"
            },
            {
              "number": "1.3.2.2",
              "title": "Safety"
            },
            {
              "number": "1.3.3",
              "title": "Other/Exploratory Objectives"
            },
            {
              "number": "1.4",
              "title": "Product Development Background"
            },
            {
              "number": "1.5",
              "title": "Overall Risk/Benefit Assessment"
            }
          ]
        },
        {
          "number": "2",
          "title": "ETHICAL CONSIDERATIONS",
          "type": "Ethics",
          "subsections": [
            {
              "number": "2.1",
              "title": "Good Clinical Practice"
            },
            {
              "number": "2.2",
              "title": "Institutional Review Board (IRB)/Independent Ethics Committee (IEC)"
            },
            {
              "number": "2.3",
              "title": "Informed Consent"
            }
          ]
        },
        {
          "number": "3",
          "title": "INVESTIGATIONAL PLAN",
          "type": "Study Design",
          "subsections": [
            {
              "number": "3.1",
              "title": "Study Design and Duration"
            },
            {
              "number": "3.2",
              "title": "Post Study Access to Therapy"
            },
            {
              "number": "3.3",
              "title": "Study Population"
            },
            {
              "number": "3.3.1",
              "title": "Inclusion Criteria"
            },
            {
              "number": "3.3.2",
              "title": "Exclusion Criteria"
            },
            {
              "number": "3.3.3",
              "title": "Women of Childbearing Potential"
            },
            {
              "number": "3.4",
              "title": "Concomitant Treatments"
            },
            {
              "number": "3.4.1",
              "title": "Prohibited and/or Restricted Treatments"
            },
            {
              "number": "3.4.2",
              "title": "Other Restrictions and Precautions"
            },
            {
              "number": "3.5",
              "title": "Discontinuation of Subjects from Treatment"
            },
            {
              "number": "3.5.1",
              "title": "Discontinuation Guidelines due to Protocol-Defined Hypoglycemia Episode or Recurrent Hypoglycemia Episodes"
            },
            {
              "number": "3.6",
              "title": "Post Study Drug Study Follow up"
            },
            {
              "number": "3.6.1",
              "title": "Withdrawal of Consent"
            },
            {
              "number": "3.6.2",
              "title": "Lost to Follow-Up"
            }
          ]
        },
        {
          "number": "4",
          "title": "STUDY DRUG",
          "type": "Treatment",
          "subsections": [
            {
              "number": "4.1",
              "title": "Investigational Product"
            },
            {
              "number": "4.2",
              "title": "Non-investigational Product"
            },
            {
              "number": "4.3",
              "title": "Storage and Dispensing"
            },
            {
              "number": "4.4",
              "title": "Method of Assigning Subject Identification"
            },
            {
              "number": "4.4.1",
              "title": "Subjects entering the 24-week double-blinded short-term treatment period"
            }
          ]
        },
        {
          "number": "9",
          "title": "STUDY MANAGEMENT",
          "type": "Other",
          "subsections": [
            {
              "number": "9.1",
              "title": "Compliance"
            },
            {
              "number": "9.1.1",
              "title": "Compliance with the Protocol and Protocol Revisions"
            },
            {
              "number": "9.1.2",
              "title": "Monitoring"
            },
            {
              "number": "9.1.3",
              "title": "Investigational Site Training"
            },
            {
              "number": "9.2",
              "title": "Records"
            },
            {
              "number": "9.2.1",
              "title": "Records Retention"
            },
            {
              "number": "9.2.2",
              "title": "Study Drug Records"
            },
            {
              "number": "9.2.3",
              "title": "Case Report Forms"
            },
            {
              "number": "9.3",
              "title": "Clinical Study Report and Publications"
            }
          ]
        },
        {
          "number": "10",
          "title": "GLOSSARY OF TERMS",
          "type": "Other"
        },
        {
          "number": "11",
          "title": "LIST OF ABBREVIATIONS",
          "type": "Other"
        },
        {
          "number": "12",
          "title": "REFERENCES",
          "type": "References"
        },
        {
          "number": "APPENDIX 1",
          "title": "NEW YORK HEART ASSOCIATION FUNCTIONAL CLASS",
          "type": "Appendix"
        },
        {
          "number": "APPENDIX 2",
          "title": "CENTRAL LABORATORY ASSESSMENTS",
          "type": "Appendix"
        },
        {
          "number": "APPENDIX 3",
          "title": "SUSTAINED ELEVATED LIVER SAFETY ABNORMALITIES FLOW CHART",
          "type": "Appendix"
        }
      ]
    }
  }
}